SEC STAFF LETTER

SEC Staff Letter Redacted Exhibit

ArriVent BioPharma, Inc. Filed 2023-10-13 Acc 9999999997-23-004535

Documents 1

SEC STAFF LETTER SEC Staff Letter Redacted Exhibit , filename1.pdf

Around this filing

2024-01-26 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2023-10-18 UPLOAD SEC-generated Letter
2023-10-13 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit

Link to a passage

External

SEC EDGAR (opens in new tab)